Extreme bipolar androgen therapy with darolutamide and testosterone cypionate in patients with metastatic castration-resistant prostate cancer: ExBAT (LACOG 0620) trial.

被引：0
|
作者：
Velho, Pedro H. Isaacsson
Girardi, Daniel da Motta
Soares, Andrey
Jardim, Denis Leonardo Fontes
Maluf, Fernando Cotait
Morbeck, Igor Alexandre
Dias, Mariane Fontes
Souza, Vinicius Carrera
E Silva, Adriano Goncalves
de Jesus, Rafaela Gomes
Rebelatto, Taiane Francieli
Bastos, Diogo Assed
机构：
[1] Hosp Moinhos De Vento, Porto Alegre, RS, Brazil
[2] Hosp Sirio Libanes, Brasilia, DF, Brazil
[3] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
[4] Grp Oncoclin, Sao Paulo, SP, Brazil
[5] Hosp Sirio Libanes, Sao Paulo, SP, Brazil
[6] Hosp Benefencia Portuguesa, Sao Paulo, SP, Brazil
[7] Grp Oncoclin, Rio De Janeiro, RJ, Brazil
[8] Hosp Alianca, Oncol DOr, Salvador, BA, Brazil
[9] Inst Canc & Transplante Curitiba ICTr, Curitiba, PR, Brazil
[10] Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil
[11] Hosp Sirio Libanes, Sao Paulo, SP, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS276
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cabazitaxel for the therapy of metastatic castration-resistant prostate cancer in the aftermath of the CHAARTED trial
    Pal, Sumanta K.
    Sonpavde, Guru
    BJU INTERNATIONAL, 2015, 116 (06) : 839 - 840
  • [32] Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer
    Jones, Robert Hugh
    Fizazi, Karim
    James, Nicholas D.
    Tammela, Teuvo L.
    Matsubara, Nobuaki
    Priou, Frank
    Beuzeboc, Philippe
    Lesimple, Thierry
    Bono, Petri
    Kataja, Vesa
    Garcia, Jorge A.
    Protheroe, Andrew
    Shore, Neal
    Aspegren, John
    Joensuu, Heikki
    Kuss, Iris
    Fiala-Buskies, Sabine
    Vjaters, Egils
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (04) : 786 - 789
  • [33] Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
    Caramella, Irene
    Dalla Volta, Alberto
    Bergamini, Marco
    Cosentini, Deborah
    Valcamonico, Francesca
    Berruti, Alfredo
    ENDOCRINE, 2022, 78 (03) : 441 - 445
  • [34] Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
    Irene Caramella
    Alberto Dalla Volta
    Marco Bergamini
    Deborah Cosentini
    Francesca Valcamonico
    Alfredo Berruti
    Endocrine, 2022, 78 : 441 - 445
  • [35] Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer
    Lam, Hung-Ming
    Corey, Eva
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [36] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [37] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
  • [38] Cost–Utility Analysis of Darolutamide Combined with Androgen Deprivation Therapy for Patients with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer in China
    Jian Ming
    Yuxia Wu
    Rong Han
    Xing Xu
    Reg Waldeck
    Shanlian Hu
    Advances in Therapy, 2023, 40 : 1087 - 1103
  • [39] Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies
    Yu, Jiwoong
    Lim, Joung Eun
    Song, Wan
    Huang, Shu-Pin
    BIOMEDICINES, 2024, 12 (01)
  • [40] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Kim, Won
    Ryan, Charles J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 189 - 200
12345